Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04637243 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Outcomes From Treatment Liver and Bile Duct Diseases

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Mar 31, 2024 to Dec 31, 2026v4
  2. Primary and study completion dates: Mar 1, 2021 to Mar 31, 2024
    • Start date: May 12, 2019 to Mar 9, 2023
    • Trial status: Completed to Active, Not Recruiting
    v3
  3. Trial status: Recruiting to Completed
    • Enrollment target: estimated 500 to confirmed 126
    • Primary and study completion dates changed from estimate of May 2025 to Mar 1, 2021
    • Site details revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
It is reported in the literature that the treatment of any liver and bile duct disease process, whether benign or malignant, continues to be a huge challenge. For example, patients with adenocarcinoma continue to be diagnosed at an advanced stage with medical and surgical options that are improving in terms of outcome measurements but with much more room for improvement. Our goal is to continue to review our treatment outcomes to further improve overall survival, overall symptom control, mortality and morbidity. The main aim of this study is to evaluate and compare the outcomes from our multiple treatments of benign or malignant liver and bile duct diseases.
Trial Details
NCT Number NCT04637243
Lead Sponsor Methodist Health System
Conditions
(from sponsor)		 Benign or Malignant Liver and Bile Duct Disease
Related terms Bile Duct Diseases
Enrollment 126 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov